×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北京... [2]
成都生物研究所 [1]
上海药物研究所 [1]
武汉大学 [1]
吉林大学白求恩第一医... [1]
复旦大学上海医学院 [1]
更多...
内容类型
期刊论文 [9]
发表日期
2019 [9]
学科主题
Chemistry ... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共9条,第1-9条
帮助
限定条件
发表日期:2019
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Discovery and Biological evaluation of pyrimido[4,5-d] pyrimidine-2,4(1H, 3H)-dione derivatives as potent Bruton's tyrosine kinase inhibitors
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 卷号: 27, 期号: 15, 页码: 3390-3395
作者:
Diao, Yanyan
;
Fang, Xiaoyu
;
Song, Peiran
;
Lai, Mengzhen
;
Tong, Linjiang
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2020/07/01
Bruton's tyrosine kinase
B-cell malignancies
Potent inhibitors
Structure-activity relationship
Cellular activities
Lactate Dehydrogenase-to-Lymphocyte Ratio Represents a Powerful Prognostic Tool of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors.
期刊论文
Pathology oncology research : POR, 2019
作者:
Li Tao
;
Li Heng
;
Xie Sheng
;
Tan Yan
;
Xie Zi-Ping
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/04
International metastatic renal cell carcinoma database consortium
Lactate dehydrogenase to lymphocytes ratio
Metastatic renal cell carcinoma
Prognostic factors
Tyrosine kinase inhibitors
Predictive value of early molecular response for deep molecular response in chronic phase of chronic myeloid leukemia
期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 15
作者:
Zhang, Chen
;
Li, Caili
;
Wang, Rui
;
Cong, Yue
;
Lin, Hai
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2019/12/05
chronic myeloid leukemia in chronic phase
deep molecular response
early molecular response
treatment-free remission
tyrosine kinase inhibitors
Enhancement of chemosensitivity by WEE1 inhibition in EGFR-TKIs resistant non-small cell lung cancer
期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 117
作者:
Liu, Di
;
Gao, Ziyang
;
Xu, Wen
;
Lin, Ge
;
Zhou, Xiao
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
Non-small cell lung cancer
WEE1
Drug resistance
EGFR
Tyrosine kinase inhibitors
Chemotherapy
Prognostic value of EGFR 19-del and 21-L858R mutations in patients with non-small cell lung cancer
期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 18, 期号: 4
作者:
Hong, Weiwei
;
Wu, Qiuji
;
Zhang, Junhong
;
Zhou, Yunfeng
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
non-small cell lung cancer
tyrosine kinase inhibitors
exon 19 deletion
21-L858R mutation
progression-free survival
SPOCK1 contributes to the third-generation EGFR tyrosine kinase inhibitors resistance in lung cancer.
期刊论文
Journal of cellular biochemistry, 2019
作者:
Yujuan Gao
;
Min Yu
;
Miao Ma
;
Yi Zhuang
;
Xiaohua Qiu
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/17
SPOCK1
non-small cell lung cancer (NSCLC)
third-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) resistance
The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
期刊论文
2019, 卷号: 10, 期号: 9, 页码: 1985-1990
作者:
Wang, Chunyu
;
Lu, Xiaotong
;
Zhou, Zongmei
;
Wang, Jingbo
;
Hui, Zhouguang
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
non-small cell lung cancer
EGFR mutation
brain metastases
radiation
tyrosine kinase inhibitors
Clinicopathologic characteristics and outcome of patients with different EGFR mutations
期刊论文
2019, 卷号: 15, 期号: 3, 页码: 166-171
作者:
Zhou, Shengyu
;
Hu, Xingsheng
;
Wang, Yan
;
Li, Junling
;
Zhou, Liqiang
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
EGFR-tyrosine kinase inhibitors
icotinib
nonsmall cell lung cancer
uncommon EGFR mutations
Natural products as important tyrosine kinase inhibitors
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 182, 页码: 111664
作者:
Yin, Bo
;
Fang, Dong-Mei
;
Zhou, Xian-Li
;
Gao, Feng
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2021/11/04
Natural products
Tyrosine kinase inhibitors
Bcr-Abl
JAK-STAT
EGFR
VEGFR
IGF-1R
c-Met(HGFR)
PDGFR
FGFR
HER-2/neu
©版权所有 ©2017 CSpace - Powered by
CSpace